NO951081L - Aminoalkylbenzoksazolinoner og benzotiazolinoner - Google Patents

Aminoalkylbenzoksazolinoner og benzotiazolinoner

Info

Publication number
NO951081L
NO951081L NO951081A NO951081A NO951081L NO 951081 L NO951081 L NO 951081L NO 951081 A NO951081 A NO 951081A NO 951081 A NO951081 A NO 951081A NO 951081 L NO951081 L NO 951081L
Authority
NO
Norway
Prior art keywords
alkyl
substd
alkoxy
aralkyl
cycloalkyl
Prior art date
Application number
NO951081A
Other languages
English (en)
Other versions
NO304689B1 (no
NO951081D0 (no
Inventor
Ange Mouithys-Mickalad
Patrick Depreux
Daniel Lesieur
Gerard Adam
Daniel-Henri Caignard
Pierre Renard
Marie-Claire Rettori
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO951081D0 publication Critical patent/NO951081D0/no
Publication of NO951081L publication Critical patent/NO951081L/no
Publication of NO304689B1 publication Critical patent/NO304689B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO950795A 1994-03-22 1995-03-21 Aminoalkylbenzoksazolinoner og benzotiazolinoner NO304689B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403298A FR2717810B1 (fr) 1994-03-22 1994-03-22 Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (3)

Publication Number Publication Date
NO951081D0 NO951081D0 (no) 1995-03-21
NO951081L true NO951081L (no) 1995-09-25
NO304689B1 NO304689B1 (no) 1999-02-01

Family

ID=9461264

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950795A NO304689B1 (no) 1994-03-22 1995-03-21 Aminoalkylbenzoksazolinoner og benzotiazolinoner

Country Status (17)

Country Link
US (3) US5534511A (no)
EP (1) EP0673933B1 (no)
JP (1) JP2705788B2 (no)
CN (1) CN1055924C (no)
AT (1) ATE197450T1 (no)
AU (1) AU680717B2 (no)
CA (1) CA2145026A1 (no)
DE (1) DE69519315T2 (no)
DK (1) DK0673933T3 (no)
ES (1) ES2153457T3 (no)
FI (1) FI951297L (no)
FR (1) FR2717810B1 (no)
GR (1) GR3035175T3 (no)
NO (1) NO304689B1 (no)
NZ (1) NZ270760A (no)
PT (1) PT673933E (no)
ZA (1) ZA952333B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717810B1 (fr) * 1994-03-22 1996-04-26 Adir Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP0785682A4 (en) * 1995-07-19 1998-10-14 Toshiba Kk LETTER BOX CONVERTER
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
FR2755690B1 (fr) * 1996-11-08 1998-12-18 Adir Nouveaux derives aminomethyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BR9814867A (pt) * 1997-10-24 2000-10-03 Warner Lambert Co Método para tratar discinesias relacionadas a doenças ou induzidas por drogas
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
DE19812331A1 (de) * 1998-03-20 1999-09-23 Merck Patent Gmbh Piperidinderivate
US7794761B2 (en) * 2000-04-13 2010-09-14 Seroctin Research & Technology, Inc. Methods for inducing anti-anxiety and calming effects in animals and humans
US20040192669A1 (en) * 2000-04-13 2004-09-30 Rosenfeld Mark J. Novel compounds for use in weight loss and appetite suppression in humans
US7524877B2 (en) 2003-11-20 2009-04-28 Seroctin Research & Technology, Inc. Compounds for use in weight loss and appetite suppression in humans
ES2332597T3 (es) 2004-05-27 2010-02-09 Ucb Pharma S.A. Derivados de benzoxazolona, procedimientos para su preparacion y su uso.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2536749A1 (fr) * 1982-11-25 1984-06-01 Cerm Cent Europ Rech Mauvernay (amino-2 ethyl)-6 benzoxazolinones substituees, leur preparation et leurs applications en therapeutique
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
FR2643634A1 (fr) * 1989-02-28 1990-08-31 Adir Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2674524B1 (fr) 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2717810B1 (fr) * 1994-03-22 1996-04-26 Adir Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
FR2717810A1 (fr) 1995-09-29
DE69519315T2 (de) 2001-05-31
US5688811A (en) 1997-11-18
JPH07258233A (ja) 1995-10-09
ATE197450T1 (de) 2000-11-11
US5688820A (en) 1997-11-18
CA2145026A1 (fr) 1995-09-23
FI951297A0 (fi) 1995-03-20
AU1498895A (en) 1995-09-28
EP0673933B1 (fr) 2000-11-08
NO304689B1 (no) 1999-02-01
NO951081D0 (no) 1995-03-21
NZ270760A (en) 1996-03-26
CN1112114A (zh) 1995-11-22
FI951297A7 (fi) 1995-09-23
ZA952333B (en) 1995-12-15
AU680717B2 (en) 1997-08-07
EP0673933A1 (fr) 1995-09-27
JP2705788B2 (ja) 1998-01-28
US5534511A (en) 1996-07-09
FR2717810B1 (fr) 1996-04-26
FI951297L (fi) 1995-09-23
CN1055924C (zh) 2000-08-30
DK0673933T3 (da) 2001-01-02
PT673933E (pt) 2001-02-28
GR3035175T3 (en) 2001-04-30
DE69519315D1 (de) 2000-12-14
ES2153457T3 (es) 2001-03-01

Similar Documents

Publication Publication Date Title
DE3683175D1 (de) Azolylmethyloxirane - ihre herstellung und verwendung als pflanzenschutzmittel.
DE69028136D1 (de) Alkoxyiminoacetamid-Derivate und ihre Verwendung als pilztötendes Mittel
NO951081D0 (no) Aminoalkylbenzoksazolinoner og benzotiazolinoner
DE2966163D1 (en) Process for the preparation of phosphorus-containing cyanhydrine derivatives and those cyanhydrine derivatives
DK0421364T3 (da) Pleuromutiliner
ES2112845T3 (es) Derivados de la morfolinurea.
ES409488A1 (es) Procedimiento para la preparacion de derivados de triazoli-lorganofosforo.
FI872555A0 (fi) Antiallergiska och antiinflammatoriska aemnen.
PT88406A (pt) Process for preparing piperidine of morpholine sulphonamide antiarrhytmic agents
AU528634B2 (en) Pyrimido- and imidazo-pyroindole derivatives
DK0455052T3 (da) 5-(1,2,4-triazol-1-ylmethyl)-isoxazolin
EP0379085A3 (de) Phenylalkylamine und diese enthaltende Fungizide
ATE142620T1 (de) 1-alkyl-2-acyl-1,2-disulfonylhydrazine mit antineoplastischer aktivität
DE3772966D1 (de) Biozide.
HUT43598A (en) Process for production of derivatives of new 4-hidroxiquinoline carbonic acid and medical compound containing thereof
ES8502699A1 (es) Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas
NO951082L (no) Aminoalkylbenzotiazolinoner
DK149883A (da) Heterocyclisk fungicid
PT75981B (en) Process for the preparation of n,n-dissubstituted alkenamides and phenyl alkenamides
IT1253699B (it) Fotoiniziatori ossaziridinici per polimerizzazioni radicaliche
BR8204149A (pt) Processo para a preparacao de esteres substituidos de acid fenil-ciclopropanocarboxilico composicoes pesticidas processos para o combate de pragas e para a preparacao de composicoes
DK162981C (da) Analogifremgangsmaade til fremstilling af kvaternaere ammoniumsalte af 1-aryl-5-amino-1-penten-3-oner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003